Covestor’s Whitehawk Therapeutics WHWK Stock Holding History

Covestor’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10	Closed	–	–	2835
2023 Q4	$0	Buy	10 +1	+11%	+$4	﹤0.01%	2810
2023 Q3	$0	Buy	9 +3	+50%	+$17	﹤0.01%	2808
2023 Q2	$0	Buy	+6	New	+$47	﹤0.01%	2748

Other funds holding WHWK

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Covestor's WHWK Position: Q1 2024 in Review

Covestor sold out of Whitehawk Therapeutics (WHWK) in Q1 2024, closing a stake of 10 shares.

Covestor first reported a position in WHWK in Q2 2023 and held it in 3 quarters. The position peaked at $0 in Q4 2023. 60 funds tracked by Wall St. Rank hold WHWK as of Q1 2024.

Covestor reported no remaining Whitehawk Therapeutics position as of Q1 2024 after selling out during the quarter.
Covestor sold 10 Whitehawk Therapeutics shares in Q1 2024.
Covestor first reported a position in Whitehawk Therapeutics in Q2 2023 and held it in 3 quarters.
Covestor's Whitehawk Therapeutics position peaked at $0 in Q4 2023.
60 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2024.

Based on Covestor's 13F filing for Q1 2024, filed 10 May 2024.